Oleg V. Malinin

Oleg V. Malinin

Auto-generated profile, based on publicly available information

Oleg V. Malinin

Izhevsk State Medical Academy

Research Focus & Metrics

Academic Career Length

34Years (1993-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 March 2017 in Infectious Diseases
Verified
Journal Article
Closed access
OMOleg V. Malinin
Oleg V. Malinin
APAlexander Platonov
Alexander Platonov
Intravenous ribavirin has been reported to be an effective treatment for haemorrhagic fever with renal syndrome (HFRS) caused by Hantaan virus in Asia. However, its therapeutic benefits for HFRS caused by Puumala virus (PUUV) in Europe are still unknown. A randomized, open-label study of efficacy and safety of intravenous ribavirin in the treatment of HFRS was conducted in the European part of Russia. Seventy-three patients with suspected HFRS within 4 d of the onset of the disease were randomized to receive either intravenous ribavirin (33 mg/kg, followed by 16 mg/kg given every 6 h for 4 d and by 8 mg/kg given every 8 h for 3 d) plus standard therapy (n = 37) or standard therapy alone (n = 36). The primary outcome was the average change from baseline in viral load over time estimated as area under the viral load curve minus baseline (AUCMB). Fifty-five patients with HFRS confirmed by nested reverse transcriptase - polymerase chain reaction (PCR) assay were included in the assessment of the efficacy. All patients entered into the clinical trial were included in the assessment of the safety. PUUV was detected in all cases of confirmed HFRS. Viral load kinetics were similar in both treatment groups. Significantly more patients receiving ribavirin than standard therapy experienced low haemoglobin level (95% vs 36%), hyperbilirubinemia (81% vs 3%), sinus bradycardia (43% vs 14%), and rash (19% vs 0%). Results of the study showed insufficient efficacy and safety of intravenous ribavirin in the treatment of HFRS caused by PUUV.

1 January 2012
Verified
Journal Article
Closed access
DSD S Sarksyan
D S Sarksyan
APAlexander Platonov
Alexander Platonov
LKL S Karan
L S Karan
IMI E Malinin
I E Malinin
LKL I Khalitova
L I Khalitova
VMV V Maleev
V V Maleev

6 June 2022 in European Journal of Clinical Microbiology & Infectious Diseases
Verified
Journal Article
Closed access
PDF file
OMOleg V. Malinin
Oleg V. Malinin
NKNikolay A. Kiryanov
Nikolay A. Kiryanov

1 January 2015 in Terapevticheskii arkhiv
Verified
Journal Article
Closed access
APAlexander Platonov
Alexander Platonov
DSD. S. Sarksyan
D. S. Sarksyan
LKL. S. Karan
L. S. Karan
GSGerman Shipulin
German Shipulin
EGE. V. Gordygina
E. V. Gordygina
VMV. V. Maleev
V. V. Maleev
To study blood coagulation and microcirculatory disorders as a possible cause of transient dysfunctions of organs (the kidney, liver, heart, lung, etc.) in patients with ixodid tick-borne borreliosis caused by Borrelia miyamotoi (Bmt). SUBJECTS AND METHODS; Twenty-four patients with Lyme disease (LD) and 28 Bmt patients treated at Izhevsk City Hospital (Udmurtia) were examined in the study. Platelet counts and the presence of D-dimers were determined; activated partial thromboplastin time, prothrombin time, thrombin time, fibrinogen and antithrombin III levels, and Factor XIIa-dependent fibrin clot lysis time were measured. Slit lamp microscopy of the conjunctiva was. also carried out. Results. Platelet counts'were less than 150,000 per pL of blood in 43% of the Bmt patients. All the Bmt patients had at least one abnormal coagulation parameter of the eight ones that were tested; 64% of them had marked coagulation disorders with three or more abnormal laboratory findings. In contrast, all the eight parameters were normal in 71% of the LD patients. The other seven LD patients had only one or two abnormal coagulation parameters (p < 0.001 in comparison with Bmt patients). Microscopic examination of eye capillary blood flow revealed pathological findings that included aggregates of erythrocytes and obstructed and/or sinuous capillaries in 22 (79%) of the Bmt patients, but none of the LD patients. A total of 14 Bmt patients had both coagulation and microcirculatory abnormalities. Eleven of them also had transient signs of organ dysfunction. As far as Borrelia secrete no known toxins, we hypothesized that uncovered disorders of blood coagulation and microcirculation in Bmt patients may contribute to organ dysfunction.

29 July 2025 in The Russian Archives of Internal Medicine
Verified
Journal Article
Open access
PDF file
OMO. V. Malinin
O. V. Malinin
Current treatment of hemorrhagic fever with renal syndrome (HFRS) is primarily based on expert opinion and data from small observational studies, the results of which are not always confirmed in clinical practice. Due to the lack of effective antiviral agents for the treatment of HFRS, the search for optimal supportive therapy continues. The clinical course of HFRS is characterized by the sequential development of phases of fever, hypotension, oliguria, polyuria and convalescence; each of these phases is characterized by certain pathophysiological mechanisms, knowledge of which is necessary for the correct management of patients with HFRS. This narrative review provides the pathophysilogic rationale and practical experience of using treatment methods for HFRS, such as anti-inflammatory therapy, correction of fluid, electrolyte, hemodynamic and hemocoagulation disorders, as well as, renal replacement therapy and symptomatic therapy.

1 July 1993
Verified
Journal Article
Closed access
PSP N Sharaev
P N Sharaev
VRV I Riabov
V I Riabov
GGG Kh Gumiarova
G Kh Gumiarova
FKF G Koz'Min
F G Koz'Min
OMO V Malinin
O V Malinin
LSL A Sorokina
L A Sorokina